Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis
Identifieur interne : 001129 ( Main/Exploration ); précédent : 001128; suivant : 001130Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis
Auteurs : Yavuz Pehlivan [Turquie] ; Bunyamin Kisacik [Turquie] ; Vuslat Kecik Bosnak [Turquie] ; Ahmet Mesut Onat [Turquie]Source :
- BMJ Case Reports [ 1757-790X ] ; 2013.
English descriptors
- Teeft :
- Arthritis, Case report, Case reports, Clinical features, Concomitant diagnosis, Disease activity score, Further permission, Gaziantep, Gaziantep university, Pehlivan, Pred, Pulmonary aspergillosis, Reactivation, Rheumatoid, Rheumatoid arthritis, Rituximab, Same time, Tender joints, Unexpected outcome, Weight loss.
Abstract
Demonstrating the efficiency and safety of rituximab (Rtx) in the treatment of active rheumatoid arthritis (RA) and tuberculosis (TB). Two cases of RA with active TB were followed up to 3 years following the initiation of Rtx. The former case presented with a history of concomitant diagnosis of both RA and TB and the latest one, also diagnosed with RA and reactivation of TB developed during the anti-tumour necrosis factor treatment. After a sufficient time of follow-up, we have observed that Rtx seems to be safer and efficient in the treatment of active RA and TB.
Url:
DOI: 10.1136/bcr-2012-006585
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002008
- to stream Istex, to step Curation: 002008
- to stream Istex, to step Checkpoint: 000181
- to stream Main, to step Merge: 001130
- to stream Main, to step Curation: 001129
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis</title><author><name sortKey="Pehlivan, Yavuz" sort="Pehlivan, Yavuz" uniqKey="Pehlivan Y" first="Yavuz" last="Pehlivan">Yavuz Pehlivan</name></author><author><name sortKey="Kisacik, Bunyamin" sort="Kisacik, Bunyamin" uniqKey="Kisacik B" first="Bunyamin" last="Kisacik">Bunyamin Kisacik</name></author><author><name sortKey="Bosnak, Vuslat Kecik" sort="Bosnak, Vuslat Kecik" uniqKey="Bosnak V" first="Vuslat Kecik" last="Bosnak">Vuslat Kecik Bosnak</name></author><author><name sortKey="Onat, Ahmet Mesut" sort="Onat, Ahmet Mesut" uniqKey="Onat A" first="Ahmet Mesut" last="Onat">Ahmet Mesut Onat</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:F6E6903B4FA2E458672E605AA3390F09A72F2667</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1136/bcr-2012-006585</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-BMWKBWQF-M/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002008</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002008</idno><idno type="wicri:Area/Istex/Curation">002008</idno><idno type="wicri:Area/Istex/Checkpoint">000181</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000181</idno><idno type="wicri:Area/Main/Merge">001130</idno><idno type="wicri:Area/Main/Curation">001129</idno><idno type="wicri:Area/Main/Exploration">001129</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis</title><author><name sortKey="Pehlivan, Yavuz" sort="Pehlivan, Yavuz" uniqKey="Pehlivan Y" first="Yavuz" last="Pehlivan">Yavuz Pehlivan</name><affiliation wicri:level="1"><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Rheumatology, Gaziantep University, Gaziantep</wicri:regionArea><wicri:noRegion>Gaziantep</wicri:noRegion></affiliation></author><author><name sortKey="Kisacik, Bunyamin" sort="Kisacik, Bunyamin" uniqKey="Kisacik B" first="Bunyamin" last="Kisacik">Bunyamin Kisacik</name><affiliation wicri:level="1"><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Rheumatology, Gaziantep University, Gaziantep</wicri:regionArea><wicri:noRegion>Gaziantep</wicri:noRegion></affiliation></author><author><name sortKey="Bosnak, Vuslat Kecik" sort="Bosnak, Vuslat Kecik" uniqKey="Bosnak V" first="Vuslat Kecik" last="Bosnak">Vuslat Kecik Bosnak</name><affiliation wicri:level="1"><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Infectious Diseases and Clinical Microbiology, Gaziantep University, Gaziantep</wicri:regionArea><wicri:noRegion>Gaziantep</wicri:noRegion></affiliation></author><author><name sortKey="Onat, Ahmet Mesut" sort="Onat, Ahmet Mesut" uniqKey="Onat A" first="Ahmet Mesut" last="Onat">Ahmet Mesut Onat</name><affiliation wicri:level="1"><country xml:lang="fr">Turquie</country><wicri:regionArea>Department of Rheumatology, Gaziantep University, Gaziantep</wicri:regionArea><wicri:noRegion>Gaziantep</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">BMJ Case Reports</title><title level="j" type="abbrev">BMJ Case Reports</title><idno type="eISSN">1757-790X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2013">2013</date><biblScope unit="volume">2013</biblScope></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Arthritis</term><term>Case report</term><term>Case reports</term><term>Clinical features</term><term>Concomitant diagnosis</term><term>Disease activity score</term><term>Further permission</term><term>Gaziantep</term><term>Gaziantep university</term><term>Pehlivan</term><term>Pred</term><term>Pulmonary aspergillosis</term><term>Reactivation</term><term>Rheumatoid</term><term>Rheumatoid arthritis</term><term>Rituximab</term><term>Same time</term><term>Tender joints</term><term>Unexpected outcome</term><term>Weight loss</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Demonstrating the efficiency and safety of rituximab (Rtx) in the treatment of active rheumatoid arthritis (RA) and tuberculosis (TB). Two cases of RA with active TB were followed up to 3 years following the initiation of Rtx. The former case presented with a history of concomitant diagnosis of both RA and TB and the latest one, also diagnosed with RA and reactivation of TB developed during the anti-tumour necrosis factor treatment. After a sufficient time of follow-up, we have observed that Rtx seems to be safer and efficient in the treatment of active RA and TB.</div></front></TEI><affiliations><list><country><li>Turquie</li></country></list><tree><country name="Turquie"><noRegion><name sortKey="Pehlivan, Yavuz" sort="Pehlivan, Yavuz" uniqKey="Pehlivan Y" first="Yavuz" last="Pehlivan">Yavuz Pehlivan</name></noRegion><name sortKey="Bosnak, Vuslat Kecik" sort="Bosnak, Vuslat Kecik" uniqKey="Bosnak V" first="Vuslat Kecik" last="Bosnak">Vuslat Kecik Bosnak</name><name sortKey="Kisacik, Bunyamin" sort="Kisacik, Bunyamin" uniqKey="Kisacik B" first="Bunyamin" last="Kisacik">Bunyamin Kisacik</name><name sortKey="Onat, Ahmet Mesut" sort="Onat, Ahmet Mesut" uniqKey="Onat A" first="Ahmet Mesut" last="Onat">Ahmet Mesut Onat</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001129 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001129 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:F6E6903B4FA2E458672E605AA3390F09A72F2667
|texte= Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis
}}
| This area was generated with Dilib version V0.6.33. |  |